Filed: 11/12/2024ACC: 0001172661-24-004568
📋 What this filing means
EAGLE HEALTH INVESTMENTS LP filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $528.00M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$528.00M
Total AUM (reported)
6.10M
Total Shares
Allocation by class
COM$397.95M75.4%
SPONSORED ADR$40.65M7.7%
SHS$37.58M7.1%
COM PAR $.01$37.50M7.1%
NAMEN AKT$9.26M1.8%
COM NEW$3.63M0.7%
ADS$1.44M0.3%
Portfolio Concentration
Top 3$145.92M27.6%
4–10$232.73M44.1%
11–25$149.35M28.3%
Top 3 weight
27.6%
Top 10 weight
71.7%
Voting Authority Distribution
Total shares with voting rights: 6.10M
Sole
Full voting authority
6.10M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
NATERA INC
SOLEShares431.31K
TypeSH
Market value$54.76M
10.37%
Sole
431.31K
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares387.35K
TypeSH
Market value$50.51M
9.57%
Sole
387.35K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares74.99K
TypeSH
Market value$40.65M
7.70%
Sole
74.99K
Shared
0.00
None
0.00
ICON PLC
SOLEShares130.79K
TypeSH
Market value$37.58M
7.12%
Sole
130.79K
Shared
0.00
None
0.00
INSMED INC
SOLEShares513.70K
TypeSH
Market value$37.50M
7.10%
Sole
513.70K
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares544.20K
TypeSH
Market value$37.07M
7.02%
Sole
544.20K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares561.70K
TypeSH
Market value$31.20M
5.91%
Sole
561.70K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares451.49K
TypeSH
Market value$30.27M
5.73%
Sole
451.49K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares50.70K
TypeSH
Market value$29.64M
5.61%
Sole
50.70K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares419.21K
TypeSH
Market value$29.47M
5.58%
Sole
419.21K
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares136.60K
TypeSH
Market value$28.83M
5.46%
Sole
136.60K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares76.26K
TypeSH
Market value$20.97M
3.97%
Sole
76.26K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares54.10K
TypeSH
Market value$19.39M
3.67%
Sole
54.10K
Shared
0.00
None
0.00
PROCEPT BIOROBOTICS CORP
SOLEShares233.09K
TypeSH
Market value$18.68M
3.54%
Sole
233.09K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares128.60K
TypeSH
Market value$14.82M
2.81%
Sole
128.60K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares330.83K
TypeSH
Market value$14.70M
2.78%
Sole
330.83K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares197K
TypeSH
Market value$9.26M
1.75%
Sole
197K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares462.91K
TypeSH
Market value$5.00M
0.95%
Sole
462.91K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares43.20K
TypeSH
Market value$4.74M
0.90%
Sole
43.20K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares7.39K
TypeSH
Market value$3.63M
0.69%
Sole
7.39K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares45K
TypeSH
Market value$2.85M
0.54%
Sole
45K
Shared
0.00
None
0.00
TRANSMEDICS GROUP INC
SOLEShares18.06K
TypeSH
Market value$2.84M
0.54%
Sole
18.06K
Shared
0.00
None
0.00
WEREWOLF THERAPEUTICS INC
SOLEShares700K
TypeSH
Market value$1.48M
0.28%
Sole
700K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares46.30K
TypeSH
Market value$1.44M
0.27%
Sole
46.30K
Shared
0.00
None
0.00
GRAIL INC
SOLEShares53.12K
TypeSH
Market value$731.0K
0.14%
Sole
53.12K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NATERA INCSOLE | COM | 431.31K | SH | $54.76M 10.37% | 431.31K | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 387.35K | SH | $50.51M 9.57% | 387.35K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 74.99K | SH | $40.65M 7.70% | 74.99K | 0.00 | 0.00 |
ICON PLCSOLE | SHS | 130.79K | SH | $37.58M 7.12% | 130.79K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 513.70K | SH | $37.50M 7.10% | 513.70K | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | COM | 544.20K | SH | $37.07M 7.02% | 544.20K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 561.70K | SH | $31.20M 5.91% | 561.70K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 451.49K | SH | $30.27M 5.73% | 451.49K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 50.70K | SH | $29.64M 5.61% | 50.70K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 419.21K | SH | $29.47M 5.58% | 419.21K | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 136.60K | SH | $28.83M 5.46% | 136.60K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 76.26K | SH | $20.97M 3.97% | 76.26K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 54.10K | SH | $19.39M 3.67% | 54.10K | 0.00 | 0.00 |
PROCEPT BIOROBOTICS CORPSOLE | COM | 233.09K | SH | $18.68M 3.54% | 233.09K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 128.60K | SH | $14.82M 2.81% | 128.60K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 330.83K | SH | $14.70M 2.78% | 330.83K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 197K | SH | $9.26M 1.75% | 197K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 462.91K | SH | $5.00M 0.95% | 462.91K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 43.20K | SH | $4.74M 0.90% | 43.20K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 7.39K | SH | $3.63M 0.69% | 7.39K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 45K | SH | $2.85M 0.54% | 45K | 0.00 | 0.00 |
TRANSMEDICS GROUP INCSOLE | COM | 18.06K | SH | $2.84M 0.54% | 18.06K | 0.00 | 0.00 |
WEREWOLF THERAPEUTICS INCSOLE | COM | 700K | SH | $1.48M 0.28% | 700K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 46.30K | SH | $1.44M 0.27% | 46.30K | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 53.12K | SH | $731.0K 0.14% | 53.12K | 0.00 | 0.00 |